David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Will we see a Tea Tree Oil Rosacea Topical?

Will we see a Tea Tree Oil Rosacea Topical?

  Given that the Ivermectin-based topical Soolantra has emerged as a viable topical treatment for the papules and pustules of rosacea, might rosacea sufferers expect to see a tea tree oil based topical in the future? One of the claimed methods of action of Ivermectin is common to tea tree oil – namely the eradication […]

Continue Reading

Severe rosacea treated with Accutane, Prednisolone, Azithromycin, Mirvaso, and Metrogel

Severe rosacea treated with Accutane, Prednisolone, Azithromycin, Mirvaso, and Metrogel

This paper from Drugs R&D, details an extensive treatment regimen undertaken to deal with a patient with a severe case of rosacea. Click the photo above for a larger view of their symptoms and how they improved over time. Note that only one side of their face was treated with Mirvaso in the hours before […]

Continue Reading

Best Practices for Treating Rosacea

Best Practices for Treating Rosacea

This paper, a sponsored supplement in the DermatologyTimes is detailing the latest and greatest treatments for rosacea. Drs. Baldwin, Bhatia, Del Rosso, Stein-Gold, and Webster are asked a series of questions relating to their clinical experience in treating rosacea. Best Practices in the Treatment of Rosacea In this Dermatology Times supplement, a group of experts in […]

Continue Reading

Mirvaso and Rhofade are very different indeed

Mirvaso and Rhofade are very different indeed

Some laboratory based research has for the first time given us a highly detailed view of the method of action of 2 recently approved treatments for the redness of rosacea. The two treatments, brimonidine based Mirvaso, and oxymetazoline based Rhofade have been shown by this research to differ in their method of action. Although brimonidine […]

Continue Reading

Rhofade may come with a heart valve damage risk

Rhofade may come with a heart valve damage risk

A recently published paper that seeks to compare the actions of oxymetazoline (Rhofade) and brimonidine (Mirvaso) has raised a possible safety issue with the action of oxymetazoline. The paper states the safety issue as; As the 5-HT2B receptor is potentially involved in drug-induced valvulopathy, the benefit/risk ratio (of Rhofade ed.) should be carefully considered, especially in […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.